Ludwigshafen, Germany

Peter Wilke

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Peter Wilke in Self-Emulsifying Formulations

Introduction

Peter Wilke is an accomplished inventor based in Ludwigshafen, Germany. He has made significant contributions to the field of life sciences through his innovative work on self-emulsifying formulations. His expertise in this area has led to the development of a unique patent that addresses the needs of the pharmaceutical industry.

Latest Patents

Peter Wilke holds a patent for a "Self-emulsifying active substance formulation and use of this formulation." This invention relates to self-emulsifying formulations that are based on an active ingredient component and a formulation base containing a lipid component and a binder component. The patent outlines the use of this formulation as a dosage form in the life science sector. Additionally, it describes a process for producing these formulations by mixing the components to create a plastic mixture, which can be manufactured as a dosage form through melt extrusion. The formulations are designed to spontaneously form emulsions in water or aqueous media.

Career Highlights

Peter Wilke is currently employed at AbbVie Deutschland GmbH & Co. KG, where he continues to innovate and contribute to the field of life sciences. His work has been instrumental in advancing the understanding and application of self-emulsifying formulations.

Collaborations

Throughout his career, Peter has collaborated with notable colleagues, including Gunther Berndl and Jörg Breitenbach. These collaborations have further enriched his research and development efforts.

Conclusion

Peter Wilke's contributions to the field of self-emulsifying formulations demonstrate his commitment to innovation in the life sciences. His patent and ongoing work at AbbVie highlight the importance of his research in developing effective dosage forms.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…